Antibody-drug conjugates specifically regulate tumor microenvironment:A promising strategy for pancreatic cancer treatmentOA
Antibody-drug conjugates specifically regulate tumor microenvironment:A promising strategy for pancreatic cancer treatment
Jia-Le Zhang;Lin-Wei Zhu;Jia Ji;Tao-Ming Tang;Miao-Jin Zhu;Hang-Ping Yao
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,ChinaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China||Jinan Microecological Biomedicine Shandong Laboratory,Jinan 250021,China
Pancreatic cancerAntibody-drug conjugatesTumor microenvironmentClinical trials
Pancreatic cancerAntibody-drug conjugatesTumor microenvironmentClinical trials
《国际肝胆胰疾病杂志（英文版）》 2026 (2)
125-133,9
This study was supported by grants from the National Natural Science Foundation of China(82473937),and Zhejiang Plan for the Special Support for Top-notch Talents of China(2022R52029).
评论